BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 26189086)

  • 1. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine screening practice patterns within a large multispecialty ophthalmic practice.
    Au A; Parikh V; Modi YS; Ehlers JP; Schachat AP; Singh RP
    Am J Ophthalmol; 2015 Sep; 160(3):561-568.e2. PubMed ID: 26116260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
    Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.
    Jivrajka RV; Genead MA; McAnany JJ; Chow CC; Mieler WF
    Eye (Lond); 2013 Sep; 27(9):1044-52. PubMed ID: 23764990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.